Examkin

Question

Difficulty: MediumInfectious Diseases

Match each clinical presentation of community-acquired pneumonia (CAP) with the most appropriate empiric antimicrobial regimen based on current clinical guidelines.

  • A 24-year-old woman with no significant past medical history diagnosed with community-acquired pneumonia in the ambulatory clinic.Oral amoxicillin monotherapy
  • A 68-year-old man with chronic obstructive pulmonary disease and poorly controlled diabetes diagnosed with community-acquired pneumonia in the ambulatory clinic.Oral amoxicillin-clavulanate and azithromycin
  • A 50-year-old man without significant comorbidities who requires hospital admission to the general medical ward for community-acquired pneumonia.Intravenous ceftriaxone and azithromycin
  • A 45-year-old woman admitted to the intensive care unit for rapidly progressive community-acquired pneumonia that developed five days after an influenza A infection.Intravenous ceftriaxone, azithromycin, and vancomycin

Answer

Healthy outpatients match with oral amoxicillin; outpatients with comorbidities match with oral amoxicillin-clavulanate and azithromycin; general ward inpatients match with intravenous ceftriaxone and azithromycin; and ICU inpatients with recent influenza match with intravenous ceftriaxone, azithromycin, and vancomycin.
The correct matches strictly follow the ATS/IDSA guidelines for community-acquired pneumonia, which stratify therapy based on outpatient vs. inpatient status, the presence of comorbidities, and specific risk factors for resistant organisms like MRSA.

Step-by-Step Solution

1
Assess the site of care for each patient based on clinical severity.
Patients 1 and 2 are treated in the outpatient setting. Patient 3 is admitted to the general medical ward. Patient 4 is admitted to the intensive care unit.
The initial branch point in community-acquired pneumonia treatment algorithms is determining the appropriate site of care (outpatient, inpatient floor, or ICU).
2
Evaluate each patient for the presence of major comorbidities or specific risk factors.
Patient 1 has no comorbidities. Patient 2 has COPD and diabetes. Patient 3 has no specific risk factors. Patient 4 has a recent influenza infection.
Comorbidities require expanding outpatient coverage to include beta-lactamase producing bacteria. A recent influenza infection significantly increases the risk of secondary methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
3
Select the guideline-recommended empiric antimicrobial regimen for each stratified patient profile.
Patient 1: Amoxicillin. Patient 2: Amoxicillin-clavulanate and azithromycin. Patient 3: Ceftriaxone and azithromycin. Patient 4: Ceftriaxone, azithromycin, and vancomycin.
This step ensures comprehensive coverage of expected typical and atypical pathogens while adhering to antibiotic stewardship principles by avoiding unnecessarily broad agents.

Key Concept

Empiric antimicrobial selection for community-acquired pneumonia is stratified by the required site of care (outpatient vs. inpatient ward vs. intensive care unit), the presence of patient comorbidities, and specific risk factors for resistant pathogens such as MRSA.
Estimated Time:2m 0s
Rate this question

Topics

Infectious Diseases

More questions from this topic